NDC properties for NDC 9 0591-2921
NDC item 00591292102
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-02 |
NDC Item | 00591292102 |
packaging | 2 BOTTLE, PUMP in 1 CARTON (0591-2921-02) / 75 g in 1 BOTTLE, PUMP (0591-2921-18) |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
NDC item 00591292118
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-18 |
NDC Item | 00591292118 |
packaging | 75 g in 1 BOTTLE, PUMP |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
NDC item 00832112140
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-40 |
NDC Item | 00832112140 |
packaging | 60 in 1 BOTTLE, PUMP |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
NDC item 00832112142
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-42 |
NDC Item | 00832112142 |
packaging | 2 BOTTLE, PUMP in 1 CARTON (0832-1121-42) / 60 GEL, METERED in 1 BOTTLE, PUMP (0832-1121-40) |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
NDC item 21922001947
NDC 9 | 21922-019 |
---|---|
NDC 10 | 21922-019-47 |
NDC Item | 21922001947 |
packaging | 2 CONTAINER in 1 CARTON (21922-019-47) / 75 g in 1 CONTAINER |
ANDA | ANDA212984 |
DCSA | CIII |
FDA SPL set id | 855168 |
Labeler | Encube Ethicals Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |